Author

Daniel Bergemalm 1

1 Faculty of Medicine and Health, Örebro University,Örebro,Sweden

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish National Quality Registry for IBD, SWIBREG

Carl Eriksson, Isabella Visuri, Daniel Bergemalm, Sara Rundquist, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Ruzan Udumyan, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid, Jonas Halfvarson

COMPREHENSIVE CIRCULATORY TRANSCRIPTOME AND PROTEOMIC PROFILING IN NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES: A MULTI-CENTRE COHORT STUDY  

Rahul Kalla, AleT Adams, Jonas Lindstrom, Morten Harald Vatn, Jørgen Jahnsen, Petr Ricanek, Daniel Bergemalm, Johan D. Söderholm, Marieke J. Pierik, Fernando Gomollon Garcia, Mauro D'Amato, Jonas Halfvarson, Jack Satsangi

DYSBIOSIS OF THE GUT MICROBIOTA IN RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

Petr Ricanek, Rahul Kalla, Yolanda Ber, simen vatn, Magdalena Kauczynska Karlsson, Lene Finnby, Daniel Bergemalm, Adam Carstens, Johan D. Söderholm, Jørgen Jahnsen, Fernando Gomollón, Jonas Halfvarson, Jack Satsangi, Christina Casén, Morten Harald Vatn

LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY

Isabella Visuri, Carl Eriksson, Sara Karlqvist, VYRON LYKIARDOPOULOS, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson

Markers of systemic inflammation in preclinical ulcerative colitis

Daniel Bergemalm, Erik Andersson, Pontus Karling, Carl Eriksson, Dirk Repsilber, Johan Hultdin, Jonas Halfvarson

Item 1 - 5 / 5
1